1-10 of 10
Andrew Sharf
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Reduced Intensity Continuous Infusion Busulfan for Allogeneic Hematopoietic Cell Transplant Patients with Hematologic Disorders Who Are Ineligible or Inappropriate for Treatment with a More Intensive Therapeutic Regimen: LCCC 0306

Reed Friend, MD, James Xenakis, Jonathan S Serody, MD, Terrance Comeau, MD, Don A. Gabriel, MD PhD, Stefanie Sarantopoulos, MD PhD, James Coghill, MD, William A. Wood, MD MPH, Andrew Sharf, Julia S Whitley, BS, Kamakshi Rao, PharmD, Christine M Walko, PharmD,BCOP, Anastasia Ivanova, PhD, Thomas C. Shea, MD, Paul M Armistead, MD PhD
Journal: Blood
Blood (2015) 126 (23): 3117.
https://doi.org/10.1182/blood.V126.23.3117.3117
Published: 2015
Journal Articles

Increased BCR responsiveness in B cells from patients with chronic GVHD

Jessica L. Allen, Prasanthi V. Tata, Matthew S. Fore, Jenna Wooten, Sharmistha Rudra, Allison M. Deal, Andrew Sharf, Todd Hoffert, Philip A. Roehrs, Thomas C. Shea, Jonathan S. Serody, Kristy L. Richards, Madan Jagasia, Stephanie J. Lee, David Rizzieri, Mitchell E. Horwitz, Nelson J. Chao, Stefanie Sarantopoulos
Journal: Blood
Blood (2014) 123 (13): 2108–2115.
https://doi.org/10.1182/blood-2013-10-533562
Published: 2014
Includes: Supplemental data
Journal Articles

BCR Hyper-Responsiveness In B Cells From Patients With Chronic Gvhd Is Blocked With The Syk Inhibitor R406

Jessica L. Allen, PhD, Prasanthi V. Tata, MS, Jenna Wooten, PhD, Matthew S. Fore, Allison M. Deal, MS, Andrew Sharf, Todd Hoffert, Philip A. Roehrs, MD, Paul M. Armistead, MD, PhD, James Coghill, MD, William A. Wood, MD, MPH, Thomas C. Shea, M.D., Jonathan Serody, MD, Kristy L. Richards, MD PhD, Madan Jagasia, MBBS, MS, Stephanie J. Lee, MD, MPH, Krista Rowe, RN, MSN, David Rizzieri, MD, Mitchell E. Horwitz, MD, Nelson J. Chao, MD, Stefanie Sarantopoulos, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 910.
https://doi.org/10.1182/blood.V122.21.910.910
Published: 2013
Journal Articles

B cells from patients with chronic GVHD are activated and primed for survival via BAFF-mediated pathways

Jessica L. Allen, Matthew S. Fore, Jenna Wooten, Philip A. Roehrs, Nazmim S. Bhuiya, Todd Hoffert, Andrew Sharf, Allison M. Deal, Paul Armistead, James Coghill, Don A. Gabriel, Robert Irons, Amber Essenmacher, Thomas C. Shea, Kristy Richards, Corey Cutler, Jerome Ritz, Jonathan Serody, Albert S. Baldwin, Stefanie Sarantopoulos
Journal: Blood
Blood (2012) 120 (12): 2529–2536.
https://doi.org/10.1182/blood-2012-06-438911
Published: 2012
Journal Articles

Effectiveness and Potential Strategies to Improve Outcomes Following Chemomobilization with Etoposide + G-CSF in Patients Undergoing Autologous Stem Cell Transplantation for Lymphoma

William A Wood, MD, MPH, Julia Whitley, BS, Ravi K Goyal, Paul M Brown, PhD, Andrew Sharf, Robert N Irons, PA, Kamakshi Rao, PharmD, Amber N Essenmacher, PA, Jonathan Serody, MD, James Coghill, MD, Paul M. Armistead, MD, PhD, Stefanie Sarantopoulos, MD, PhD, Don A. Gabriel, MD, PhD, Thomas C. Shea, MD
Journal: Blood
Blood (2011) 118 (21): 2083.
https://doi.org/10.1182/blood.V118.21.2083.2083
Published: 2011
Journal Articles

B Cells Are Primed for Survival by BAFF-Driven Bim Degradation In Chronic Graft Versus Host Disease (cGVHD) Patients

Jenna Wooten, PhD, Bhuiya S. Nazmim, MPH, Kristy Richards, PhD, MD, Andrew Sharf, Joseph H. Antin, MD, Robert J. Soiffer, MD, Jerome Ritz, MD, Thomas C. Shea, MD, Jonathan Serody, MD, Albert S. Baldwin, Jr., Ph.D., Stefanie Sarantopoulos, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 216.
https://doi.org/10.1182/blood.V116.21.216.216
Published: 2010
Journal Articles

Mitoxantrone and Melphalan as Conditioning Regimen for Autologous Stem Cell Transplant for Multiple Myeloma.

Anne W. Beaven, MD, Terrance Comeau, MD, Andrew Sharf, RN, Dominic T. Moore, MPH, Jonathan Serody, MD, PhD, Thomas C. Shea, MD, Don A. Gabriel, MD, PhD
Journal: Blood
Blood (2006) 108 (11): 2945.
https://doi.org/10.1182/blood.V108.11.2945.2945
Published: 2006
Journal Articles

Long Term Effects on GVHD and Survival Following the Use of G-CSF Stimulated Bone Marrow Versus G-CSF Mobilized Peripheral Blood Stem Cells in HLA Matched Sibling Transplant.

Anne W. Beaven, MD, Thomas C. Shea, MD, Don A. Gabriel, MD, PhD, Terrance Comeau, MD, Robert Irons, PA, Dominic T. Moore, MS, MPH, Li Lin, MS, Andrew Sharf, RN, Carol Krasnov, Mark E. Brecher, MD, Jonathan Serody, MD, PhD
Journal: Blood
Blood (2005) 106 (11): 5385.
https://doi.org/10.1182/blood.V106.11.5385.5385
Published: 2005
Journal Articles

Clinical and Pharmacokinetic Results of a Four-Day Continuous Infusion of Full-Dose Busulfan in Patients (pts) Undergoing Matched Related (MRD) or Unrelated (MUD) Stem Cell Transplant (SCT).

Thomas C. Shea, MD, Christine Walko, PharmD, Don Gabriel, MD, PhD, Jon Serody, MD, PhD, Terrance Comeau, MD, Robert Irons, PA, Andrew Gilman, MD, Carol Krasnov, Andrew Sharf, RN, Celeste Lindley, PharmD
Journal: Blood
Blood (2005) 106 (11): 1752.
https://doi.org/10.1182/blood.V106.11.1752.1752
Published: 2005
Journal Articles

High Relapse Rate Following Alemtuzamab Use in Allogeneic Transplants for Myeloid Hematologic Malignancies.

Thomas C. Shea, MD, Jonathan Serody, MD, PhD, Don Gabriel, MD, PhD, Terrance Comeau, MD, Donald Harvey, PharmD, Robert Irons, PA, David Morris, MD, Andrew Sharf, RN, Carol Krasnov, Cherie Dunphy, MD, Nicholas Banderenko, MD, Mark Brecher, MD
Journal: Blood
Blood (2004) 104 (11): 1826.
https://doi.org/10.1182/blood.V104.11.1826.1826
Published: 2004